Tuberculosis
📧 Sign up to get email alerts when something new happens for Tuberculosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-05-31Clinical Trial Update: A Study of the Immunogenicity of M. Bovis BCG, Delivered Intradermally in Healthy Volunteers [Phase 1]
The University of Oxford conducted a Phase 1 study to evaluate the immunogenicity of intradermal Mycobacterium bovis BCG in healthy voluntee…
-
CLINICAL_TRIALS trial_result · 2007-05-31Clinical Trial Update: A Study of the Immunogenicity of BCG, Delivered Intradermally in Healthy Volunteers [NA]
An update on a completed study evaluating the immunogenicity of intradermal Bacille Calmette-Guérin (BCG) vaccine in healthy volunteers.
-
CLINICAL_TRIALS trial_result · 2007-03-19Clinical Trial Update: TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment [Phase 2]
A Phase 2 trial comparing moxifloxacin to ethambutol for treatment of pulmonary tuberculosis has completed.
-
CLINICAL_TRIALS trial_result · 2007-02-12Clinical Trial Update: Food Incentives for TB Treatment Compliance in East Timor (FITTCET) [NA]
This clinical trial evaluated whether providing food incentives improves tuberculosis treatment adherence in East Timor; the study has compl…
-
CLINICAL_TRIALS trial_result · 2007-01-29Clinical Trial Update: A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG [Phase 1]
A Phase I trial evaluated the safety and immunogenicity of a recombinant MVA-based vaccine encoding Mycobacterium tuberculosis antigen 85A, …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-01-29Clinical Trial Update: A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Received BCG Immunisation 1 Month Previously [Phase 1]
Phase 1 study assessing safety and immunogenicity of a recombinant MVA vaccine encoding antigen 85A (MVA-85A) delivered intradermally in hea…
-
CLINICAL_TRIALS trial_result · 2007-01-18Clinical Trial Update: A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers. [Phase 1]
Phase I study evaluating safety and immunogenicity of a recombinant MVA vaccine encoding antigen 85A for tuberculosis, delivered intradermal…
-
CLINICAL_TRIALS trial_result · 2007-01-18Clinical Trial Update: A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers [Phase 1]
Phase I trial assessing safety and immunogenicity of the MVA85A TB vaccine in healthy Gambian volunteers has been completed. The study evalu…
-
CLINICAL_TRIALS trial_result · 2007-01-11Clinical Trial Update: Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis [Phase 4]
A Phase 4 trial comparing three regimens for chemoprophylaxis of tuberculosis in patients co-infected with HIV has completed.
-
CLINICAL_TRIALS trial_result · 2006-12-15Clinical Trial Update: Investigation of a Novel Approach to Improve Treatment Success Rates for Tuberculosis Patients in Senegal [Phase 4]
Phase 4 clinical trial in Senegal assessing a novel approach to improve treatment success rates for tuberculosis patients has completed.